Comparative analysis of clonal evolution among patients with right-sided colon cancer, left-sided colon cancer and rectal cancer

Author:

Banerjee SantasreeORCID,Zhang Xianxiang,Kuang Shan,Wang Jigang,Li Lei,Fan Guangyi,Luo Yonglun,Sun ShuaiORCID,Han Peng,Wu Qingyao,Yang Shujian,Ji Xiaobin,Li Yong,Deng Li,Tian Xiaofen,Wang Zhiwei,Zhang Yue,Wu Kui,Zhu Shida,Bolund Lars,Yang Huanming,Xu Xun,Liu Junnian,Lu Yun,Liu Xin

Abstract

AbstractBackgroundTumor multi-region sequencing reveals intratumor heterogeneity (ITH) and clonal evolution which play a key role in progression and metastases of the tumor. However, large-scale high depths multiregional sequencing of colorectal cancer (CRC) has not been well studied. In addition, the comparative analysis among right-sided colon cancer (RCC), left-sided colon cancer (LCC) and rectal cancer (RC) patients as well as the study of lymph node metastasis (LN) with extranodal tumor deposits (ENTD) from evolutionary perspective remain unknown.ResultsIn this prospective study, we recruited different stages of 68 CRC patients with RCC (18), LCC (20) and RC (30). We performed high-depth whole exome sequencing (WES) of 206 tumor regions including 176 primary tumors, 19 LN and 11 ENTD samples. Our results showed ITH with a Darwinian pattern of evolution. We identified that the evolution pattern of LCC and RC was more complex and divergent than RCC, suggesting the evolutionary diversity in the initiation and progression of LCC and RC. Genetic and evolutionary evidences found that both LN and ENTD were of polyclonal in origin. Moreover, ENTD was a distinct entity from LN and evolved later.ConclusionsIn conclusion, our study showed the Darwinian pattern of evolution with differences in clonal evolution between RCC with LCC and RC.

Publisher

Cold Spring Harbor Laboratory

Reference35 articles.

1. World Health Organization. Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer. Accessed January 21, 2019.

2. International Agency for Research on Cancer. Cancer Today. https://gco.iarc.fr/today/. Accessed January 21, 2019.

3. Toward understanding and exploiting tumor heterogeneity

4. Genetic heterogeneity and cancer drug resistance

5. Whole genomes redefine the mutational landscape of pancreatic cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3